Martin Shkreli Insider Profile
18 Followers
Martin Shkreli, Fmr Officer Dir 10% Sharehldr at Travere Therapeutics, holds 2.08M shares in Humanigen (Ticker: HGENQ), holds 1.77M shares in Travere Therapeutics (Ticker: TVTX). Most recently, Martin Shkreli Sold ― shares of Humanigen on Aug 29, 2016 for an estimated value of $6.89M.
Martin Shkreli's Trading History
| HGENQHumanigen | Aug 29, 2016 | ― | Informative Sell | 6.89M | $22.83K | |
| TVTXTravere Therapeutics | Nov 23, 2014 | Fmr Officer Dir 10% Sharehldr | Informative Sell | 10.36M | $89.41M |
You May Also Like
Martin Shkreli insider profile FAQ
What is the percentage of profitable transactions made by Martin Shkreli?
The percentage of profitable transactions made by Martin Shkreli is 26%.
What is the average return per transaction made by Martin Shkreli?
The average return per transaction made by Martin Shkreli is -16.00%.
What stocks does Martin Shkreli hold?
Martin Shkreli holds: TVTX, HGENQ stocks.
What was Martin Shkreli’s latest transaction?
Martin Shkreli’s latest transaction was an Informative Sell of $6.89M.
What was Martin Shkreli's most profitable transaction?
Martin Shkreli’s most profitable transaction was an Informative Buy of HGENQ stock on November 18, 2015. The return on the trade was 78.20%.
What is Martin Shkreli's role in Travere Therapeutics?
Martin Shkreli's role in Travere Therapeutics is Fmr Officer Dir 10% Sharehldr.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
